SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Institute of Experimental Hematology

  •  

     The Institute of Experimental Hematology investigates the biology of blood cell formation and function with a special focus on genetic cell modification as a new therapeutic modality.

     

     

     Our research groups collaborate to form a portfolio ranging from the generation and expansion of stem cells to the control or enhancement of cell differentiation and function.  We connect basic research and strong translational efforts in the field of molecular cell modification for the treatment of severe blood diseases, such as immune disorders and leukemia. The detection and prevention of risks associated with genetic cell modification and training of young scientists are important missions of our Institute.

     

     

     The Institute of Experimental Hematology contributes to strong research networks of Hannover Medical School, including the DFG-funded cluster of excellence REBIRTH, the collaborative research center SFB738, and the Integrated  Research  and  Treatment  Center  for  Transplantation  Medicine  (IFB-Tx) . Furthermore,  we  participate  in  the  DFG-funded  research priority   program   “mechanisms  of   gene  vector  entry  and persistence” (SPP1230), several network projects supported by the BMBF  and the DAAD and integrated projects of the EU (SCID-NET).

     

     

  • Prof. Dr. med.
    Axel Schambach, PhD
    (Acting Director)

     

    Medizinische Hochschule Hannover  
    Institut Experimentelle Hämatologie
    - OE 6960 -
    Carl-Neuberg-Str. 1
    D-30625 Hannover

    Tel.: +49  511 532 - 5170/6067

    Fax: +49 511 532 - 6068

    E-Mail:  schambach.axel[at]mh-hannover.de